4.7 Article

Anti-Alzheimers molecular mechanism of icariin: insights from gut microbiota, metabolomics, and network pharmacology

Related references

Note: Only part of the references are listed.
Review Biochemistry & Molecular Biology

Molecular Mechanisms of Neuroinflammation in Aging and Alzheimer's Disease Progression

Felicia Liana Andronie-Cioara et al.

Summary: Aging is a major risk factor for late-onset Alzheimer's disease, which is associated with chronic inflammation in both the peripheral and central nervous system. The accumulation of amyloid beta significantly enhances neuroinflammation and accelerates the progression of the disease through various pathways. Targeting neuroinflammation could be a promising therapeutic strategy, although further research is needed to determine the optimal timing.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Cell Biology

Icariin ameliorates memory deficits through regulating brain insulin signaling and glucose transporters in 3xTg-AD mice

Fei Yan et al.

Summary: Icariin improves learning and memory impairments in an Alzheimer's disease mouse model by regulating brain insulin signaling and glucose transporters.

NEURAL REGENERATION RESEARCH (2023)

Article Integrative & Complementary Medicine

Proapoptotic Effect of Icariin on Human Ovarian Cancer Cells via the NF-κB/PI3K-AKT Signaling Pathway: A Network Pharmacology-Directed Experimental Investigation

Jingjing Gao et al.

Summary: The study identified the pharmacodynamic targets and key mechanisms of icariin in treating ovarian cancer using network pharmacology tools and bioinformatics databases. It was found that icariin acts on ovarian cancer through various kinases, targeting important genes such as TNF, MMP9, and STAT3. Additionally, icariin was observed to promote apoptosis in SKOV3 cells by influencing the NF-kappa B and PI3K-AKT pathways, ultimately inhibiting tumor growth.

AMERICAN JOURNAL OF CHINESE MEDICINE (2022)

Review Microbiology

Mass spectrometry-based metabolomics in microbiome investigations

Anelize Bauermeister et al.

Summary: Mass spectrometry-based metabolomics is a key technology for detecting and identifying small molecules produced by the human microbiota and understanding their functional role. Microbiotas play a malleable part in ecosystems, affecting not only their specific niche but also distant environments. Data analysis, especially in the context of microbiome analysis, remains a challenge, with emphasis placed on integrative approaches and the integration of microbiome sequencing data.

NATURE REVIEWS MICROBIOLOGY (2022)

Review Biochemistry & Molecular Biology

Bioavailability Improvement Strategies for Icariin and Its Derivates: A Review

Robert Szabo et al.

Summary: In recent years, there has been considerable interest in icariin and its derivatives, but their low bioavailability has hindered their potential beneficial effects. Researchers have developed various strategies to improve the bioavailability of these compounds.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Review Nutrition & Dietetics

Overlapping Mechanisms of Action of Brain-Active Bacteria and Bacterial Metabolites in the Pathogenesis of Common Brain Diseases

Tanja Patricia Eicher et al.

Summary: This article discusses the impact of the microbiota-gut-brain axis on the pathophysiology of seven brain-related diseases, highlighting changes in bacterial abundance and the metabolic implications, and indicating that all seven diseases are associated with a leaky gut, neuroinflammation, and over-activated microglial cells.

NUTRIENTS (2022)

Article Pharmacology & Pharmacy

Untargeted metabolomics analysis of the hippocampus and cerebral cortex identified the neuroprotective mechanisms of Bushen Tiansui formula in an aβ25-35-induced rat model of Alzheimer's disease

Hongli Li et al.

Summary: This study investigated the neuroprotective mechanisms of Bushen Tiansui Formula (BSTSF) against Alzheimer's disease (AD) by analyzing metabolite profiles in the hippocampus and cortex of AD rats. The results showed that BSTSF significantly improved memory deficits and typical histopathological changes in AD rats. Metabolomics analysis revealed that BSTSF treatment ameliorated metabolic disorders in the hippocampus and cerebral cortex, suggesting its neuroprotective effects against AD.

FRONTIERS IN PHARMACOLOGY (2022)

Article Physiology

System level modeling and analysis of TNF-α mediated sphingolipid signaling pathway in neurological disorders for the prediction of therapeutic targets

Sanam Banaras et al.

Summary: The sphingomyelin signaling pathway plays a crucial role in neurodegenerative disorders and is associated with TNF-alpha, offering important insights for disease therapeutics.

FRONTIERS IN PHYSIOLOGY (2022)

Article Immunology

Gut Microbiota Dysbiosis Induced by Decreasing Endogenous Melatonin Mediates the Pathogenesis of Alzheimer's Disease and Obesity

Boqi Zhang et al.

Summary: This study investigates the systemic changes and pathogenic risks in an endogenous melatonin reduction (EMR) mouse model and identifies a new relationship between melatonin, Alzheimer's disease (AD), and gut microbiota. The findings suggest that EMR causes systemic changes mediated by gut microbiota dysbiosis, which may be a pathogenic factor for AD and obesity. The study also highlights the potential of targeting the gut microbiota for the prevention and treatment of AD and obesity.

FRONTIERS IN IMMUNOLOGY (2022)

Article Oncology

AKT1/FOXP3 axis-mediated expression of CerS6 promotes p53 mutant pancreatic tumorigenesis

Dachuan Qi et al.

Summary: This study identified a positive correlation between high CerS6 expression and worse prognosis in PDAC patients, establishing CerS6 as a potential biomarker for PDAC; CerS6 promotes cell proliferation, colony formation, and invasion by producing C16-ceramide and is required for tumor formation; The AKT1/FOXP3 axis mediates CerS6 expression and promotes p53 mutant pancreatic tumorigenesis by inducing excessive C16-ceramide accumulation.

CANCER LETTERS (2021)

Review Biochemistry & Molecular Biology

Neurodegenerative Disorders: Spotlight on Sphingolipids

Frida Mandik et al.

Summary: Neurodegenerative diseases are incurable disorders of the nervous system characterized by progressive loss of brain areas and neuronal subtypes, often associated with symptoms linked to affected brain regions. Common features include protein deposition and mitochondrial damage affecting energy production and mitophagy. Research in the past decade has highlighted the role of lipids, particularly sphingolipids, in the pathogenesis of neurodegenerative diseases.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Review Biochemistry & Molecular Biology

Icariin ameliorate Alzheimer's disease by influencing SIRT1 and inhibiting Aβ cascade pathogenesis

Yaochen Chuang et al.

Summary: Alzheimer's disease, with the highest proportion of cases among all types of dementia, is closely associated with the aggregation of amyloid-beta protein. Icariin, the main ingredient extracted from Epimedium, may ameliorate Alzheimer's disease by regulating Sirtuin1 to inhibit amyloid-beta protein and improve other amyloid-beta cascade pathogenesis, providing a reference for future treatment strategies.

JOURNAL OF CHEMICAL NEUROANATOMY (2021)

Article Plant Sciences

Cardioprotective effect of icariin against myocardial fibrosis and its molecular mechanism in diabetic cardiomyopathy based on network pharmacology: Role of ICA in DCM

Liping Zhang et al.

Summary: This study identified four potential target genes involved in diabetic cardiomyopathy and demonstrated the protective effects of icariin (ICA) in a rat model of type 2 diabetes mellitus. ICA treatment ameliorated structural damage, myocardial fibrosis, and abnormal calcium influx in diabetic rats. The results suggest that ICA could be an effective treatment for diabetic cardiomyopathy by targeting specific genes and pathways.

PHYTOMEDICINE (2021)

Article Geriatrics & Gerontology

Inhibition of Rho Kinase by Fasudil Ameliorates Cognition Impairment in APP/PS1 Transgenic Mice via Modulation of Gut Microbiota and Metabolites

Yuqing Yan et al.

Summary: This study demonstrated that Fasudil improved spatial memory in a mouse model of Alzheimer's disease. By analyzing gut microbiota and metabolites, it was found that Fasudil reversed abnormal microbiota and regulated metabolisms in AD mice, suggesting a novel therapeutic strategy for Alzheimer's disease.

FRONTIERS IN AGING NEUROSCIENCE (2021)

Article Immunology

Integrating Serum Metabolome and Gut Microbiome to Evaluate the Benefits of Lauric Acid on Lipopolysaccharide- Challenged Broilers

Yanping Wu et al.

Summary: The study demonstrated that Lauric acid (LA) pretreatment in broilers under lipopolysaccharide (LPS) challenge significantly alleviated weight loss and intestinal mucosal injuries, enhanced immune functions, and modulated serum metabolism and gut microbiota, showing potential as a dietary supplement to combat bacterial LPS challenge in animal production and promote food safety.

FRONTIERS IN IMMUNOLOGY (2021)

Article Immunology

Bioinformatics and Network Pharmacology Identify the Therapeutic Role and Potential Mechanism of Melatonin in AD and Rosacea

Huaxiong Zhang et al.

Summary: This study identified common molecular regulatory networks between rosacea and dementia, suggesting melatonin as a potential therapeutic drug for both conditions by modulating inflammation and vascular signaling pathways. The findings support melatonin's role in treating rosacea and dementia through its effects on inflammatory cytokine secretion and cell migration.

FRONTIERS IN IMMUNOLOGY (2021)

Review Medicine, Research & Experimental

Physiological functions and therapeutic applications of neutral sphingomyelinase and acid sphingomyelinase

Hongjiao Xiang et al.

Summary: Sphingomyelin can be converted into ceramide by neutral and acid sphingomyelinases, which play key roles in regulating cell growth and apoptosis, as well as in various diseases such as cancer and cardiovascular diseases. Therapeutic applications of NSM and ASM show promising potential in clinical treatments.

BIOMEDICINE & PHARMACOTHERAPY (2021)

Article Immunology

Biochemically deleterious human NFKB1 variants underlie an autosomal dominant form of common variable immunodeficiency

Juan Li et al.

Summary: NFKB1 deficiency is considered the most common genetic cause of common variable immunodeficiency (CVID). This study found that a large proportion of CVID patients have loss of function or hypomorphic NFKB1 variants, while the majority of variants in the general population or patients with unrelated conditions are neutral. The enrichment of deleterious NFKB1 variants in CVID patients is significantly higher than in other populations.

JOURNAL OF EXPERIMENTAL MEDICINE (2021)

Article Pharmacology & Pharmacy

Metabolomics and integrated network pharmacology analysis reveal Tricin as the active anti-cancer component of Weijing decoction by suppression of PRKCA and sphingolipid signaling

Jia-Xin Li et al.

Summary: The study found that the active compound Tricin in the Weijing formula targets PRKCA to suppress cancer cell growth in treating NSCLC. In vitro experiments showed vital effects of Tricin on Lewis lung carcinoma cells. The study concluded that Weijing formula and Tricin are promising alternative treatments for NSCLC patients.

PHARMACOLOGICAL RESEARCH (2021)

Article Pharmacology & Pharmacy

Icariin enhances youth-like features by attenuating the declined gut microbiota in the aged mice

Xiaoang Li et al.

Summary: Icariin demonstrates anti-aging effects in aged mice by improving motor coordination and learning skills, reducing oxidative stress, enhancing intestinal integrity, and upregulating aging-related signaling molecules. The study also shows that gut microbiota plays a critical role in icariin's anti-aging abilities, making it a potential medicine for the wellness of aged adults.

PHARMACOLOGICAL RESEARCH (2021)

Review Pharmacology & Pharmacy

Functional metabolomics innovates therapeutic discovery of traditional Chinese medicine derived functional compounds

Tianyu Wang et al.

Summary: Functional metabolomics can characterize the systems therapeutic actions of TCM by capturing the molecular interactions between disease response metabolite biomarkers (DRMB) and functional compounds, which provide insights into the pharmacological efficiency and associated therapeutic mechanisms of TCM.

PHARMACOLOGY & THERAPEUTICS (2021)

Review Chemistry, Medicinal

Icariin, an Up-and-Coming Bioactive Compound Against Neurological Diseases: Network Pharmacology-Based Study and Literature Review

Shuangqiu Wang et al.

Summary: This review explores the molecular mechanisms of icariin in treating neurologic disorders, including its historical use, active components, molecular targets, and predicted therapeutic actions. The findings may guide future studies on the application of icariin in treating neurologic disorders.

DRUG DESIGN DEVELOPMENT AND THERAPY (2021)

Article Biochemistry & Molecular Biology

Akkermansia muciniphila and its outer protein Amuc_1100 regulates tryptophan metabolism in colitis

Zhenyang Gu et al.

Summary: The study suggests that the probiotic Akkermansia muciniphila (Akk) may alleviate ulcerative colitis (UC) by regulating tryptophan (Trp) metabolism, suppressing the kynurenine pathway (KP) independently of colon tissue, and promoting Trp metabolism enrichment mediated by fecal microbiota.

FOOD & FUNCTION (2021)

Review Pharmacology & Pharmacy

Network Pharmacology Databases for Traditional Chinese Medicine: Review and Assessment

Runzhi Zhang et al.

FRONTIERS IN PHARMACOLOGY (2019)

Review Immunology

Antibiotics, gut microbiota, and Alzheimer's disease

Francesco Angelucci et al.

JOURNAL OF NEUROINFLAMMATION (2019)

Review Cell Biology

Sphingolipids and their metabolism in physiology and disease

Yusuf A. Hannun et al.

NATURE REVIEWS MOLECULAR CELL BIOLOGY (2018)

Article Microbiology

Dynamics of metatranscription in the inflammatory bowel disease gut microbiome

Melanie Schirmer et al.

NATURE MICROBIOLOGY (2018)

Article Pharmacology & Pharmacy

Icariin Attenuates Interleukin-1β-Induced Inflammatory Response in Human Nucleus Pulposus Cells

Wenbin Hua et al.

CURRENT PHARMACEUTICAL DESIGN (2017)

Article Biochemistry & Molecular Biology

Synthetic ceramide analogues increase amyloid-β 42 production by modulating γ-secretase activity

Nobumasa Takasugi et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2015)

Review Cell Biology

Ceramides in Alzheimer's Disease: Key Mediators of Neuronal Apoptosis Induced by Oxidative Stress and Aβ Accumulation

Maja Jazvinscak Jembrek et al.

OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2015)

Review Neurosciences

Adult hippocampal neurogenesis and its role in Alzheimer's disease

Yangling Mu et al.

MOLECULAR NEURODEGENERATION (2011)